FDA NDA · NDA008372
ACTHAR GEL
Sponsor: MALLINCKRODT IRELAND
What this page does not claim
A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.
APPLICATION
NDA008372
TYPE
NDA
ORIGINAL APPROVAL
1952-04-29
LATEST ACTION
2026-10-05
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued, Prescription
Products
ACTHAR GELDiscontinued
CORTICOTROPIN 40 UNITS/ML · INJECTABLE · INJECTION
ACTHAR GEL (AUTOINJECTOR) · ReferencePrescription
CORTICOTROPIN 80 UNITS/ML · INJECTABLE · INJECTION
ACTHAR GEL (AUTOINJECTOR) · ReferencePrescription
CORTICOTROPIN 40 UNITS/0.5ML · INJECTABLE · INJECTION
ACTHAR GEL · ReferencePrescription
CORTICOTROPIN 80 UNITS/ML · INJECTABLE · INJECTION
Approval history
2017-07-31Labeling · Supplement 55 · standardAP
2016-04-19Manufacturing (CMC) · Supplement 51 · standardAP
2016-03-14Manufacturing (CMC) · Supplement 50 · standardAP
2016-03-11Manufacturing (CMC) · Supplement 49 · standardAP
2016-03-04Manufacturing (CMC) · Supplement 48 · standardAP
2014-01-17Manufacturing (CMC) · Supplement 47 · standardAP
2002-11-06Manufacturing (CMC) · Supplement 35 · standardAP
1999-07-15Manufacturing (CMC) · Supplement 34 · standardAP
1998-12-15Manufacturing (CMC) · Supplement 33 · standardAP
1994-04-05Manufacturing (CMC) · Supplement 31 · standardAP
1993-03-26Manufacturing (CMC) · Supplement 30 · standardAP
1992-04-22Labeling · Supplement 29AP
1985-03-25Manufacturing (CMC) · Supplement 28 · standardAP
1985-01-15Manufacturing (CMC) · Supplement 27 · standardAP
1984-08-29Manufacturing (CMC) · Supplement 26 · standardAP
1983-08-24Labeling · Supplement 25AP
1981-03-26Labeling · Supplement 24AP
1979-06-26Labeling · Supplement 21AP
1979-06-26Labeling · Supplement 18AP
1979-06-26Manufacturing (CMC) · Supplement 22 · standardAP
1979-06-26Labeling · Supplement 20AP
1978-03-14Labeling · Supplement 17AP
1977-10-05Labeling · Supplement 16AP
1977-06-01Labeling · Supplement 15AP
1952-04-29Type 5 - New Formulation or New Manufacturer · Original · standardAP
Source: FDA Drugs@FDA. Browse every approval SPEQ tracks →